StockData
Adlai Nortye Group Ltd. logo

Adlai Nortye Group Ltd. (ANL) stock

ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 10, 2026Score 0/30
$9.48−0.55 (-5.48%)

Close on Nov 17, 2026Market cap $379.20MP/E –Yield –

Adlai Nortye cash

Cash and short-term investments held at the end of each period.

Adlai Nortye's cash was $8.06M at Dec 31, 2025. For fiscal 2025 it was $8.06M, down 86.8% from the year before. The highest annual figure on record is $91.49M in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.06M-86.8%
FY2024Dec 31, 2024$60.90M-33.4%
FY2023Dec 31, 2023$91.49M+114.0%
FY2022Dec 31, 2022$42.76M-33.3%
FY2021Dec 31, 2021$64.13M+164.3%
FY2020Dec 31, 2020$24.26M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$8.06M-87.4%
Q4 FY2024Dec 31, 2024$60.90M+151.0%
Q4 FY2023Dec 31, 2023$91.49M–
Q4 FY2022Dec 31, 2022$42.76M–
Q4 FY2021Dec 31, 2021$64.13M–
Q4 FY2020Dec 31, 2020$24.26M–

More Adlai Nortye figures

See a number that looks wrong?